Is Johnson & Johnson a Buy in This Market?

→ What is Medicare Supplement Insurance? (From Tranzact) (Ad)

We discuss Johnson & Johnson as a reliable choice for investors in an unpredictable market. Being part of the consumer staples sector makes JNJ more resilient during economic downturns and despite the ongoing litigation, the upcoming earnings report is expected to be solid.

Stocks Mentioned in This Episode

Company	MarketRank™	Current Price	Dividend Yield	P/E Ratio
JNJ Johnson & Johnson	4.933 of 5 stars	$146.82 -1.2%	3.24%	9.15

Add This Stock to My Watchlist

Chris Markoch, Guest

MarketBeat Contributor, MarketBeat

Chris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.

Laycee Kluin, Host

Digital Marketing Strategist, MarketBeat

As MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.

Previous Video

All Videos

Next Video